Culture Biosciences has reeled in $5.5 million in funding to be used to expand its operations.

Velocity Clinical Research is shelling out $20 million from a recent fundraising to acquire its first three research sites.

Charles River has added another string to its early-stage R&D bow by acquiring preclinical services firm Citoxlab for $510 million in cash.

The revolving door of FDA staffers into the life science industry continues as four former executives at the U.S. regulator join the CRO’s ranks.

Aetion closes on a $27 million extension of series B financing.

Moderna has opted to enter a licensing deal with U.K.-based Avacta Group to use the U.K.-based company’s Affimer biotherapeutics and reagents.

Welsh CRO Simbec-Orion was acquired by U.K.-based private equity firm CBPE Capital for an undisclosed price.

MMS Holdings, MIT Julia Lab and the University of Maryland form the Health Analytics Collective.